4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Associations of the LIBRA risk score with cognitive resistance to susceptibility genes for dementia

      abstract

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Some older adults succeed in maintaining excellent cognition despite high genetic risk for Alzheimer’s disease (AD), reflecting cognitive resistance (CR) to potential neuropathologies. Although the etiological factors for CR are still unknown, some literature suggests that environmental/lifestyle risk factors may contribute to offset, or at least reduce, the effect of AD‐related genes on cognitive decline and dementia risk. Yet, how modifiable lifestyle and health related risk factors may promote CR in genetically at‐risk individuals remains to be elucidated.

          Method

          We selected 6,774 dementia‐free participants from the Three‐City study cohort (≥65 years), who underwent ApoE and genome‐wide genotyping, at least 2 neuropsychological evaluations over time, and had information for the LIfestyle for BRAin health (LIBRA) score at baseline. LIBRA is a validated weighted score of 12 modifiable risk factors, including unhealthy lifestyle, poor cardiometabolic health, depression and renal dysfunction, with higher scores denoting increased lifestyle‐related dementia risk. We defined high genetic risk through ApoE‐ε4 status alone or combined with high AD‐specific genetic risk scores (GRS) beyond ApoE. We operationalized the concept of CR to genetic risk based on the individual slopes of global cognition estimated using latent process mixed models adjusted for demographics and genetic risk. CR status was assigned to genetically at‐risk participants with an adjusted cognitive slope in the slowest 25% of the overall population. Finally, focusing on genetically at‐risk individuals, we examined the associations between the LIBRA score, its individual components, and CR status using separate logistic regression models adjusted for sex, age, education, and study center.

          Result

          Among genetically at‐risk participants (n = 1,336 ε4‐carriers; n = 2,065 ε4‐carriers/GRS‐high), 237 (18%) ε4‐carriers and 470 (23%) ε4‐carriers/GRS‐high were cognitively resistant to susceptibility genes. Each unit increment in the LIBRA risk score at baseline was strongly associated with lower odds of CR in ε4‐carriers (odds ratio [OR] = 0.915; 95% confidence interval [CI] = 0.865‐0.967; P = .002; Figure) and ε4‐carriers/GRS‐high (OR = 0.883; 95%CI = 0.847‐0.920; P<.0001). When examining LIBRA components, cognitive activities and history of coronary heart diseases showed the strongest independent associations with CR (all P<0.01; Figure).

          Conclusion

          Genetically at‐risk older adults can develop cognitive resistance, which may be substantially promoted by prevention programs targeting lifestyle modifications and health management.

          Related collections

          Author and article information

          Contributors
          maude_wagner@rush.edu
          Journal
          Alzheimers Dement
          Alzheimers Dement
          10.1002/(ISSN)1552-5279
          ALZ
          Alzheimer's & Dementia
          John Wiley and Sons Inc. (Hoboken )
          1552-5260
          1552-5279
          09 January 2025
          December 2024
          : 20
          : Suppl 7 ( doiID: 10.1002/alz.v20.S7 )
          : e085538
          Affiliations
          [ 1 ] Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL USA
          [ 2 ] Bordeaux Population Health Research Center, Inserm U1219, University of Bordeaux, Bordeaux France
          [ 3 ] INM, Univ Montpellier, INSERM, Montpellier France
          Author notes
          [*] [* ] Correspondence

          Maude Wagner, Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA.

          Email: maude_wagner@ 123456rush.edu

          Article
          ALZ085538
          10.1002/alz.085538
          11715481
          c6957d3a-7e1e-40b7-80d9-9460139060c7
          © 2024 The Alzheimer's Association. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

          This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

          History
          Page count
          Figures: 1, Tables: 0, Pages: 2, Words: 524
          Categories
          Public Health
          Public Health
          Poster Presentation
          Epidemiology
          Custom metadata
          2.0
          December 2024
          Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.2 mode:remove_FC converted:09.01.2025

          Comments

          Comment on this article

          Related Documents Log